Development, characterization and standardization of a nose-only inhalation exposure system for exposure of rabbits to small particle aerosols containing Francisella tularensis.
K. J. O'Malley, J. D. Bowling, E. M. Barry, K. R. O. Hazlett, D. S. Reed
Abstract
Inhalation of Francisella tularensis (Ft) causes pneumonic tularemia in humans, a severe disease with a 30-60% mortality rate. Reproducible delivery of aerosolized virulent bacteria in relevant animal models is essential for evaluating medical countermeasures. Here we developed optimized protocols for infecting New Zealand White (NZW) rabbits with aerosols containing Ft. We evaluated relative humidity, aerosol exposure technique, and bacterial culture conditions to optimize spray factor (SF), a central metric of aerosolization. This optimization reduced both inter-and intra-daily variability and were applicable to multiple isolates of Ft. Further improvements in the accuracy and precision of the inhaled pathogen dose were achieved through enhanced correlation of bacterial culture OD and CFU. Plethysmograph data collected during exposures found that respiratory function varied considerably between rabbits, was not a function of weight, and did not improve with acclimation to the system. Vaccine Strain (LVS)-vaccinated rabbits were challenged via aerosol with human-virulent Ft SCHU S4 that had been cultivated in either Mueller Hinton Broth (MHB) or Brain Heart Infusion (BHI) broth. LVS-vaccinated animals challenged with MHB-SCHU S4 experienced short febrile periods (median: 3.2 days), limited weight loss ( 10%), and median survival times that were not significantly different than unvaccinated controls. These studies highlight the importance of careful characterization and optimization of protocols for aerosol challenge with pathogenic agents.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into Francisella tularensis-specific CD8+ T cell responses.
D. E. Place, D. R. Williamson, … G. S. Kirimanjeswara·bioRxiv·Oct 10, 2017
- A vibrating mesh nebulizer as an alternative to the Collison 3-jet nebulizer for infectious disease aerobiology.
J. D. Bowling, K. J. O'Malley, … D. S. Reed·bioRxiv·Mar 31, 2019
- Characterization of a novel intratracheal aerosol challenge model of Brucella melitensis in guinea pigs
M. Hensel, D. G. Garcia-Gonzalez, … A. M. Arenas-Gamboa·bioRxiv·Oct 30, 2018
- Outer membrane tube formation by Francisella novicida involves extensive envelope modifications and is linked with type VI secretion and alterations to the host phagosomal membrane
Maheen Rashid, Shoichi Tachiyama, … David G. Thanassi·mBioPeer-reviewed·May 19, 2025
- TPR1, a novel rifampin derivative demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A Priority Pathogen F. tularensis
J. E. Cummings, K. W. Slayden, R. A. Slayden·bioRxiv·Feb 12, 2021
- The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation
Belén Borrego, Celia Alonso, … Alejandro Brun·PLoS neglected tropical diseasesPeer-reviewed·Aug 19, 2024